Gene Query: CRKL

Dataset Description Geneva Score
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 70.02
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 57.72
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 57.31
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 57.31
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 38.22
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 33.24
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 29.43
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 29.43
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 28.84
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 25.56
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 24.72
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 24.47
Triple vectors expand AAV transfer capacity in the retina 24.39
Systematic discovery of endogenous human ribonucleoprotein complexes 23.99
Gene Expression Profiling of SPOP Knocked Down Cell 23.77
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 23.27
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 21.84
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 21.62
The effect of PPARG inhibition on human angiomyolipoma cells 20.85
Effect of drugs on transcriptomic profiles 20.51
SLAM-seq for K562 endogenous mRNA decay 20.12
CD95/Fas ligand mRNA is toxic to cells 19.65
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 19.62
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 19.62
Seletive inhibition of CDK9 in DLBCL cell lines 19.09
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 18.82
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 18.65
Interphase condensins regulate ligand-depedent enhancer activation 18.02
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 18.02
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 17.59
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 17.59
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 17.28
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 16.63
ETV7 and interferon response 16.63
The pause-initiation limit restricts transcription activation in human cells 16.55
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 16.41
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 16.41
Novel Targeting of Transcription and Metabolism in Glioblastoma 16.25
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 16.2
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 16.18
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 16.17
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 15.91
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 15.83
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 15.35
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 15.17
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 15.06
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 14.57
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 14.44
Gene expression changes caused by KRAS in MCF-10A 14.35
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 14.29
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 14.22
Disruption of the exocyst induces podocyte loss and dysfunction 14.16
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 14.08
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 14.08
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 14.0
Role of XRN2 ribonucleolytic activity in RNA metabolism 13.98
Transcriptome of diurnal human blood neutrophils 13.82
Ribosomal footprinting of CN34-Parental and CN34-LM1a 13.59
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 13.48
Ribosomal footprinting of MDA-Parental and MDA-LM2 13.28
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 13.27
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 12.93
Co-regulation of splicing by Rbfox1 and hnRNP M 12.92
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 12.92
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 12.8
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 12.73
RNA transcriptome analysis during HSV-1 infection 12.61
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 12.6
11.99
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 11.87
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 11.79
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 11.75
Spliceosomal disruption of the non-canonical BAF complex in cancer 11.73
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 11.66
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 11.34
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 11.27
Paxillin regulates genomic networks in prostate cancer [LNCaP] 11.24
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 11.18
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 11.16
Mitochondrial dsRNA triggers antiviral signalling in humans 11.09
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 11.08
RIG-I and MDA5 fRIP during KSHV lytic reactivation 11.06
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 11.0
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 10.94
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 10.94
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 10.87
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 10.85
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 10.81
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 10.81
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 10.75
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 10.69
MYC dependent mRNA translation shapes gene expression and cell biology 10.61
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 10.6
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 10.6
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 10.6
PTHrP overexpression in MCF7 cells 10.6
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 10.52
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 10.39
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 10.39
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 10.28
Profiling of escape kinetics of viruses subjected to RNAi 10.22
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 10.2
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 10.17
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 10.15
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 10.07
Knockdown of ADNP in HCT116 colon cancer cells 10.05
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 10.04
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 10.01
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 9.96
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 9.96
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 9.96
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 9.95
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 9.91
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 9.89
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 9.8
Transcriptome analysis of CNS leukemia 9.73
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 9.73
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 9.69
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 9.69
Differentially expressed vascular development genes for iPSC-ECs from CDI 9.65
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 9.65
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 9.64
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 9.63
Ebola virus (EBOV) infection of ARPE-19 cells 9.62
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 9.55
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 9.55
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 9.55
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 9.52
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 9.52
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 9.5
UV_24h_GRO-Seq 9.42
Effect of mitochondria deficiency on senescence-associated gene expression 9.37
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 9.36
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 9.31
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 9.28
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 9.25
AUF-1 affected genes in human skin cells 9.21
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 9.17
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 9.16
N6-methyladenine DNA Modification in Glioblastoma 9.14
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 9.14
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 9.14
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 9.13
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 9.13
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 9.13
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 9.09
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 9.09
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 9.09
Global analyses of the effect of different cellular contexts on microRNA targeting 9.09
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 9.04
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 9.04
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 9.0
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 9.0
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 8.99
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 8.98
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 8.98
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 8.97
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 8.96
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.92
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 8.91
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 8.88
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 8.78
3’ Uridylation Expands miRNA Target Repertoire 8.78
TFAP2C signalling in human fibroblasts 8.72
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 8.66
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.49
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.49
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 8.48
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 8.45
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 8.35
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 8.32
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 8.17
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 8.13
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 8.11
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 8.11
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 8.1
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 8.1
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 8.07
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 8.03
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 8.03
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 7.98
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 7.91
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 7.91
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 7.9
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 7.9
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 7.89
Nucleoporin-mediated regulation of cell identity genes 7.88
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 7.87
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 7.87
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 7.79
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 7.76
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 7.76
Effect of BB608 on Gene Expression in HNSCC Cell Line 7.73
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 7.72
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 7.67
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 7.66
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 7.62
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 7.58
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 7.57
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 7.53
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 7.47
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 7.46
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 7.4
DJ-1 is dispensable for human stem cell homeostasis 7.39
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 7.38
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 7.38
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 7.36
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 7.36
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 7.31
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 7.31
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 7.29
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 7.29
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 7.28
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 7.28
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 7.25
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 7.24
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 7.24
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 7.2
Gene expression profile of multiple myeloma cell lines treated with CB-5083 7.15
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 7.07
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 7.05
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 7.05
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 7.04
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 7.03
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 7.03
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 7.01
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 6.99
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 6.98
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 6.98
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 6.97
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 6.96
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 6.93
Regulation of highly expressed hCINAP on translatome 6.92
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 6.88
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 6.88
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 6.88
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 6.87
Transcriptional effect of ETV1 knockdown in melanoma cells 6.83
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 6.81
Paxillin regulates genomic networks in prostate cancer [PC3] 6.81
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 6.81
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 6.79
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 6.77
Gene expression analysis in response to hypoxic pathway inhibition 6.77
Gene Expression Profiling of WT and KDM3A Knocked out Cell 6.74
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 6.74
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 6.73
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 6.64
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 6.6
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 6.46
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 6.43
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 6.41
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 6.41
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 6.41
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 6.28
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 6.25
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.23
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 6.2
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 6.19
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 6.13
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 6.1
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 6.08
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 6.08
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 6.08
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 6.05
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 6.05
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 6.04
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 6.04
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 5.99
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 5.99
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 5.92
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 5.89
An integrative analysis of non-coding regulatory DNA variations associated with autism 5.87
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 5.85
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 5.84
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 5.82
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 5.82
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 5.8
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 5.75
LINE-2 transposable elements are a source of functional human microRNAs and target sites 5.68
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 5.6
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 5.6
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 5.44
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 5.4
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 5.36
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 5.3
Defective structural RNA processing in relapsing-remitting multiple sclerosis 5.29
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 5.29
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 5.23
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 5.22
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 5.17
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 5.16
Identification of a LIF-responsive replication-competent human β cell 5.13
METTL3 and WTAP 5.12
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 5.07
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 5.07
Determination of tRNA aminoacylation levels by high throughput sequencing 5.04
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 5.01
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 5.01
Genetic-to-epigenetic Therapy for Pancreatic Cancer 4.96
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 4.88
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 4.85
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 4.85
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 4.8
4sU-seq of HFF exposed to salt and heat stress 4.74
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 4.67
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 4.64
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 4.64
RNA-seq of RKO cells with cTAZ KO or putback 4.64
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 4.61
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 4.61
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 4.59
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 4.55
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 4.55
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 4.51
naive T cell heterogeneity after neonatal thymectomy 4.5
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 4.49
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 4.46
RNA Sequencing of Human iPS derived Cardiomyocytes 4.46
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 4.46
Transcriptomic profiling of human peripheral blood-derived mast cells 4.46
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 4.45
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 4.45
The bromodomain protein BRD4 regulates splicing during heat shock 4.43
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 4.43
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.41
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 4.3
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 4.28
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 4.27
nELAVL HITS-CLIP in Alzheimer's Disease patients 4.26
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 4.2
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  4.07
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 4.06
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 4.05
Epigenetic reprogramming of melanoma cells by vitamin C treatment 4.05
CD86 regulates a pro-survival signal in myeloma cells 4.05
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 4.03
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 4.03
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 3.96
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 3.82
Human cell line and subcutaneous tumor 3.81
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 3.73
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 3.73
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.68
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 3.6
Primate-specific gene TMEM14B promotes cortical expansion and folding 3.6
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 3.58
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.58
Expression profiling of MCF-7 cells with treatment of TCDD 3.58
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 3.58
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 3.54
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 3.54
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 3.52
Effect of ILF3 on translation during homeostasis and the antiviral response 3.44
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 3.39
Direct Isolation and Characterization of Human Nephron Progenitors. 3.35
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 3.33
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.33
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 3.3
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 3.22
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.22
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 3.2
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 3.17
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 3.16
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.13
DRB/GRO-Seq -/+ UV 3.03
Copper Regulation of HIF-1 Transcription Activity 3.02
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 3.02
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.99
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 2.93
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.92
Discovering human diabetes-risk gene function with genetics and physiological assays 2.87
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.81
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 2.8
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.75
Transcriptome analysis of peripheral blood monocytes 2.75
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 2.75
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 2.68
Comprehensive comparative analysis of 5’ end RNA sequencing methods 2.64
Capturing the Interactome of Newly Transcribed RNA 2.61
Capturing the Interactome of Newly Transcribed RNA (RICK) 2.61
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 2.52
The Genetic Landscape of Diamond-Blackfan Anemia 2.51
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.5
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.5
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.5
miR-93 Targets in Human Endothelial Cells 2.47
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 2.45
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 2.42
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.41
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 2.41
A transcriptome dataset revealing the molecular features of breast cancer stem cells 2.38
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 2.35
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 2.35
A549 cell transcriptome responses to infection with H7N9 influenza virus 2.35
Transcriptome-wide response to synthetic chromatin protein PcTF 2.29
mRNA expression profile of Lymphocytes by high-throuput sequencing 2.13
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.09
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 2.07
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.03
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 2.03
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.02
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 2.01
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.0
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 1.95
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 1.92
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 1.92
Impact on erythroid progenitor type on erythroid differntiation 1.91
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.87
m6A-dependent regulation of messenger RNA stability 1.82
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.82
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 1.78
Conservative alteration of chromosomal expression pattern across human solid tumor types 1.77
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.77
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.77
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.77
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 1.76
ADAR1-editing of cellular and measles virus-derived duplex RNA 1.76
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.74
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.69
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.65
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.61
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.61
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.54
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.54
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 1.48
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.47
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.47
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 1.46
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.44
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.43
Transposon-based construction of strand-specific RNA-seq libraries 1.41
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.41
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 1.39
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.34
Gene expression regulated by CSA and CSB in neuroblastoma cell line 1.31
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.26
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.25
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.15
High-resolution comparative analysis of great ape genomes 1.14
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.14
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 1.14
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.13
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.13
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 1.08
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.05
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 1.04
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 1.01
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.95
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.95
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.89
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.84
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.83
The pioneer factor CEBPA modulates vitamin D signaling 0.78
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.78
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.76
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.76
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.75
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.74
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.74
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.74
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 0.74
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.74
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.74
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.72
Expression analysis of the TAF1 syndrome 0.68
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.68
Dilated cardiomyopathy vs Myocarditis 0.67
Myc activation coordinates gene transcription and protein translation responses 0.64
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.64
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 0.63
RNA-seq of IL-4 stimulated human keratinocytes 0.62
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.58
Transcriptional landscape changes during human embryonic stem cell derivation 0.57
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.56
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.52
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 0.48
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 0.48
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.45
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.45
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 0.43
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.41
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.34
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.29
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.28
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.25
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.23
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.2
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.15
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.14
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.11
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.1
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.1
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.08
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.07
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.07
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.06
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.05
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.03
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation